Affinity Asset Advisors, LLC Ventyx Biosciences, Inc. Transaction History
Affinity Asset Advisors, LLC
- $596 Million
- Q2 2025
A detailed history of Affinity Asset Advisors, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 4,536,182 shares of VTYX stock, worth $13.7 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
4,536,182Holding current value
$13.7 Million% of portfolio
1.63%Shares
5 transactions
Others Institutions Holding VTYX
# of Institutions
122Shares Held
49.4MCall Options Held
70.4KPut Options Held
51.4K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.9MShares$17.9 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$14.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.16MShares$9.58 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$9.39 Million0.4% of portfolio
-
Marshall Wace, LLP London, X02.4MShares$7.26 Million0.01% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $171M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...